ArticleOncology letters2024

Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report.

Tianhao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.